Patents Assigned to Valorisation-Rechereche Société en Commandite
  • Interleukin-1 receptor antagonists, compositions, and methods of treatment
    Patent number: 8618054
    Abstract: Peptides that are designed to inhibit the biological activity of the IL-1R type 1 receptor and inhibit IL-1R/IL-1RacP related cell signaling and biological activity are disclosed. Compositions comprising IL-1R antagonists of the present invention are useful in the treatment of IL-1 related diseases or conditions such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease as well as other chronic or acute inflammatory diseases.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: December 31, 2013
    Assignees: Valorisation-Rechereche Société en Commandite, Valorisation HSJ, Société en Commandite
    Inventors: Sylvain Chemtob, Christiane Quiniou, William D. Lubell, Martin Beauchamp, Karl A. Hansford